Skip to main content
. 2019 Oct 4;18(6):6126–6142. doi: 10.3892/ol.2019.10962

Table I.

Characteristics of the studies included in the meta-analysis.

Author, year Country Series Platform HCC samples Non-HCC samples (Refs.)
Li et al, 2008 China GSE10694 GPL6542 78 88 (89)
Su et al, 2009 China GSE12717 GPL7274 10 6 (90)
Burchard et al, 2010 USA GSE22058 GPL10457 96 96 (91)
Sato et al, 2011 Japan GSE21362 GPL10312 73 73 (92)
Noh et al, 2013 South Korea GSE39678 GPL15852 16 8 (93)
Wang et al, 2012 USA GSE31383 GPL10122 9 10 (94)
Morita et al, 2016 Japan GSE41874 GPL7722 3 4 (95)
Shih et al, 2012 Taiwan GSE36915 GPL8179 68 21 (96)
Wojcicka et al, 2014 Poland GSE63046 GPL11154 24 24 (97)
Shen et al, 2014 USA GSE54751 GPL18262 10 10 (98)
Lou et al, 2019 Taiwan GSE69580 GPL10850 5 5 (99)
Murakami et al, 2015 Japan GSE57555 GPL18044 5 16 (100)
Ghosh et al, 2016 India GSE67882 GPL10850 4 8 (101)
Peng et al, 2015 USA GSE64632 GPL18116 3 3 (102)
Zhang et al, 2017 China GSE98269 GPL20712 3 3 (103)
Shi et al, 2018 China GSE115016 GPL21572 12 12 (104)
TCGA, 2018 N/A N/A N/A 372 50
Chen et al, 2013 China N/A N/A 15 15 (12)

HCC, hepatocellular carcinoma; TCGA, The Cancer Genome Atlas; N/A, not available.